Oramed Pharmaceuticals
ORMP
#9176
Rank
NZ$0.31 B
Marketcap
NZ$7.68
Share price
-0.81%
Change (1 day)
82.42%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): NZ$0.10 Billion

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of NZ$0.11 Billion, an increase over its 2024 earnings that were of -NZ$26.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.10 B-2.72%
2025 NZ$0.11 B-513.21%
2024 -NZ$26.94 Million-311.47%
2023 NZ$12.73 M-119.45%
2022 -NZ$65.47 Million39.17%
2021 -NZ$47.05 Million73.93%
2020 -NZ$27.05 Million18.53%
2019 -NZ$22.82 Million-16.62%
2018 -NZ$27.37 Million38.32%
2017 -NZ$19.79 Million12.51%
2016 -NZ$17.59 Million25.01%
2015 -NZ$14.07 Million18.18%
2014 -NZ$11.91 Million39.72%
2013 -NZ$8.52 Million46.4%
2012 -NZ$5.82 Million128.32%
2011 -NZ$2.55 Million-51.47%
2010 -NZ$5.26 Million35.21%
2009 -NZ$3.89 Million
2007 -NZ$6.11 Million607.04%
2006 -NZ$0.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
NZ$41.50 B 36,862.42%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$12.79 B 11,297.56%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-NZ$0.91 Billion-904.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$0.11 Billion-197.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
NZ$62.34 M-44.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel